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Introduction
Angiotensin converting enzymes (ACEs) are important
in the control of the cardiovascular function and their
inhibition have a primary role in the treatment of hyper-
tension and heart failure. However they have effects
beyond the cardiovascular system. Angiotensin 2 pro-
duction by ACE and stimulation of the angiotensin
1 (AT1) receptor subtype reduces nitric oxide bioavail-
ability, promotes inflammation and fibrosis. The ACE
type 2 (ACE2) increases angiotensin 1-7 production and
counterbalances ACE effects. Some animal data have
shown a beneficial role of the up-regulation of the ACE2
pathway and a detrimental role for the up-regulation of
the ACE classic pathway in different ARDS, but there are
no data in patients with ARDS.
Objectives
We compared the plasma concentrations of ACE and
ACE2 in patients with ARDS and correlated them with
ICU mortality.
Methods
We measured the plasma concentrations of ACE and
ACE2 by a quantitative ELISA method (Cloud-Clone
Corp, US) at time of diagnosis of ARDS (Berlin definition)
in 80 consecutive patients admitted to our department of
intensive care We compared the plasma concentrations of
ACE, ACE2 and ACE/ACE2 ratio between ICU survivors
and non-survivors. All analyses were performed in SPSS
22.0 and a p value < 0.05 was considered as significant. Al
values are presented as medians with p25-75.
Results
The main characteristics of the 80 consecutive ARDS
patients are presented in Table 1. The ICU mortality
was 31%. ACE was significantly higher in non-survivors
compared to survivors, but ACE2 and ACE/ACE2 ratio
were similar in survivors and non-survivors (Table 2).
The area under the curve for the receiver operator
characteristics (AUC_ROC) for the ACE to discrimi-
nate between survivors and non survivors was 0.65
(0.51-0.79).
Conclusions
Increased ACE levels are associated with worse outcome
in ARDS patients, which might indicate endothelial acti-
vation and may have implication for therapy.
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